Back to Authors

Frazer, Kelly A

0000-0002-6060-8902

Mayo Clinic

Moores Cancer Center, Department of Pediatrics and Rady Children's Hospital, Institute for Genomic Medicine, Chronic Lymphocytic Leukemia Research Consortium, University of California, San Diego, San Diego, CA.

Citations 2

Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism

Blood | August 16, 2019 | Volume: 134 | Issue: 19 | Pages: 1645-1657

10.1182/blood.2019000435 | PMID 31420334

In this work related to familial aggregation of familial venous thromboembolism, the investigators report genomic and transcriptomic association of 16 novel susceptibility loci for venous thromboembolism.
High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia

Blood | November 4, 2016 | Volume: 128 | Issue: 25 | Pages: 2931-2940

10.1182/blood-2016-04-712562 | PMID 27815263

Key Points The expression level of ROR1 on CLL cells varies between patients. High-level CLL-cell expression of ROR1 associates with more aggressive disease.